Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Ethinylestradiol/drospirenone/levomefolic acid - Bayer

Next Previous
Drug Profile

Ethinylestradiol/drospirenone/levomefolic acid - Bayer

Alternative Names: BAY98-7071; Beyaz; EE20/DRSP/L-5MTHF; ethinylestradiol/drospirenone/methyltetrahydrofolate; Safyral; Yasmin Plus; Yaz Flex Plus; Yaz Plus

Latest Information Update: 22 Mar 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Bayer
  • Class Alkylated estrogenic steroids; Androstenes; Antiandrogens; Estradiol congeners; Estrenes; Folic acids; Hormonal contraceptives; Norpregnatrienes; Oral contraceptives; Progesterone congeners; Vitamins
  • Mechanism of Action Estrogen receptor agonists; Mineralocorticoid receptor antagonists; Progesterone receptor agonists; Testosterone congener inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Acne vulgaris; Pregnancy; Premenstrual dysphoric disorder

Most Recent Events

  • 22 Mar 2022 Discontinued - Phase-III for Pregnancy (Prevention) in Mexico (PO)
  • 16 Aug 2019 No development reported - Phase-III for Pregnancy (Prevention) in Mexico (PO)
  • 20 Jul 2015 No recent reports on development identified - Preregistration for Pregnancy (Prevention) in Europe (PO)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top